Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Post by palinc2000on Nov 04, 2022 11:49am
190 Views
Post# 35073322

Good advice to cry babies found on the EDT-T message Board

Good advice to cry babies found on the EDT-T message Board

Message Board

"I'm not tapped into the timing Rikkie but I hear your frustration.

All I can do in manage my own level of frustration and choose how I react, while Mgt. hopefully gets its act together.  I have found better ways to react -  that work better for me than belly-aching on a public bulletin board, and lashing out at other posters becasue the share price hasn't done what I expect it to in teh short term.

Ten ideas for you:

1. Lower you average cost.  Sell when the hype artists appear (July '22 would have been a good month) and buy when the bashers are in full vigor (Nov/Dec '21 would have been a good time) .  I've gotten my AC down between 30 and 40 % in the past year.

2. Have a core position and a trading postion. Keep the core and trade the rest (see # 1)

3. Recognize that whining on a BB is only shooting yourself in the foot.  Newbies are scared away...and you accentuate the problem.   Maybe that is the point.  So take that into account too. 

4. Participate in financings (although I know it sucks to have to put more actual skin in the game when you're frustrated).  If you have conviction and have done your homework, it's much easier.  It's one of two ways to fight dilution.

5. Not to excuse them or to be an apologist, but recognize that some things are beyond Mgt control.   Lots of boards are filled with people blaming Mgt for this and that.  I haven't seen many Mgt teams that have been able to control for a 30% bear market or Covid-19.  Like it or not overrun/over taxed ICU's don't have time for Trials when lives are at stake.

6. Voice your concerns to the CEO and BoD directly.  They may not like talking to you, but in the end, they can't hide from you forever.

7. Understand this is an "end-game" play.   The true value of the opportuntiy will likely not ever be reflected in the SP...until one day it is.  If they reward themselves (and trust me that's the plan) then by default they will reward patient shareholders.

8. Use common sense (e.g why did JK and SA and BM leave good gigs for a "nothing burger"?)  Don't fall for the Lifestyle argument.  These guys have already made it and don't really need a salary that the average retail investor may see as exhorbidant .  They are looking for the Lifestyles of the Rich and Famous, not a "Lifestyle job".  Why did Toray and Infomed agree to extend after years of dealys?...I could go on and on.

9.  The more due diligence you do, the more your realize there is only one logical outcome. Sepsis kills 11 million/year.  PMX can be used for ARDS and Covid (IMO and I think JK and Ronco believe that as well). RCT's are hard (especially 28 day mortality ones) - "exceeding expectaions" likely means ultiimate "confirmation" .  Break through designation by teh FDA is another solid clue.  Loading up certain peeps with PSU's in another clue.  Read other Real World Evidence (I post it when I find it, but I don't spend alot of time looking for it.  I'm sure there is alot more.).  Also see Bonus below.

10. Lastly. If you can't stand the heat, get out of the kitchen.  Let that shyte go !  Move on !

Bonus:  Understand risk and probabilities. e.g what is the probability that Dialco and PMX go to zero?  If  100% success means that it's worth $ 5 - $ 10/sh (pick your own number) then what is the probabiilty of success, and value of just one coming through?..what is it worth if there is a 50% probablity of just one coming through?   What's the true risk of both flopping and no one willing to buy the IP, the secured rights to the EAA and SAMI, the Tax loss carryforwards, etc.?

Timing Hint:  Look at Sedar and understand PSU deadlines and dates. Ask yourself why the BoD built that in?  Understand Interim Data Reviews and what can happen.  Especially for treatments directed at hundreds of thousands of Americans that die each year. And if you don't beleive "they" care about the people, trust that "they" and the insurance companies care about the costs (including for dialysis)""

MM
 

<< Previous
Bullboard Posts
Next >>